In the ongoing laboratory testing for COVID-19 diagnosis by molecular diagnostic methods, clinical specimens or a subset of the clinical specimens may need to be retained for various purposes such as performing additional tests, for quality control purposes or for use as control materials to assess newer diagnostic tests.

Since the inception of the COVID-19 pandemic, ICMR has received over 190 requests for evaluation of molecules/AYUSH regimens/products/technologies/diagnostic kits, etc.

On 18 May India reached a landmark in its fight against COVID-19 by performing 100,000 tests in one day.

The scientists at ICMR-NIV, Pune have developed and validated the completely indigenous IgG ELISA test for antibody detection for SARS-CoV-2. On external validation, the IgG test kit produced by ICMR-NIV, Pune has been found to have sensitivity and specificity of 98.7% and 100% respectively. ELISA test has the advantage of processing 90 samples together in a single run of two-and-a-half hours. Moreover, ELISA based testing is easily possible even at district level as the ELISA kit has inactivated virus.

The deaths of those with negative or inconclusive test results but with symptoms of the coronavirus disease (Covid-19) will be recorded as probable Covid-19 deaths, the Indian Council of Medical Research said in fresh guidelines on recording Covid-19 deaths released on 10 May, 2020.

Republic of India (hereinafter the Recipient) will implement the Covid-19 Emergency Response and Health Systems Preparedness project (the Project), with the involvement of the following Ministries/Agencies/Units: Ministry of Health and Family Welfare (MoHFW), Indian Council of Medical Research (ICMR) and the National Center for Disease Control (

The Indian Council of Medical Research (ICMR) has obtained permission for “restricted use in public health emergency” of two second-line HIV medications for use against the novel coronavirus (nCoV)

The grave, of an unknown person, is now being called a “dargah” by a section of residents at the Muslim-majority Sooppikkada village in Kozhikode district.

2 more vaccines undergoing trial in the country.

Motorcycle-borne trained paramedic and nurse would be the first responders

Pages